AI and analytics leader brings extensive expertise in machine learning, GenAI, and life sciences decision intelligence to Lilly’s data science operations
Collaboration integrates NVIDIA accelerated computing and the NVIDIA BioNeMo platform with QIAGEN Digital Insights’ curated biomedical knowledge bases
BMS is moving beyond conversational AI into what it describes as “agentic” systems
Funding to accelerate development of integrated DNA platform supporting vaccines, gene therapies and advanced biologics
The next-generation proteomics platform powered by Olink™ Explore HT enables simultaneous analysis of thousands of proteins from a single sample
Doshi has established a strong track record in driving quality assurance, regulatory compliance, and formulation excellence across complex pharmaceutical operations
The platform combines internally developed technologies, strategic partnerships, and external AI capabilities
Funding to support clinical development, gene therapy pipeline expansion and GMP manufacturing capabilities
The company’s shares of confidence were underlined by an upgraded 2026 outlook, with Merck now expecting annual net sales of up to €21.4 billion and EBITDA pre of as much as €6.1 billion
We are building an AI-native operating system for pharma sales and distribution
Subscribe To Our Newsletter & Stay Updated
_256_275.jpeg)
